FAP and neoplasm: Suppression of tumor growth was observed for the LL/2 stromal FAP+ cell depletion group (Ly5.1 → FAP-TK) and, to a lesser extent, for the hematopoietic FAP+ depletion group (FAP-TK → Ly5.1) compared with PBS injected controls (Figure 5D).